Clinical Trial Update: GOREISAN for Heart Failure (GOREISAN-HF) Trial [Phase 4]

View source ↗

Summary

Phase 4 trial update showing GOREISAN for heart failure is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• GOREISAN

Snippet

Sponsor: Takeshi Morimoto | Conditions: Heart Failure, Edema | Phase 4 | Status: ACTIVE_NOT_RECRUITING